Anixa Biosciences, Inc.

2.40 USD
-0.12 (-4.76%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Anixa Biosciences, Inc. stock is down -9.77% since 30 days ago. The next earnings date is Sep 4, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 9 June’s closed higher than May. 100% of analysts rate it a buy.

About Anixa Biosciences, Inc.

Anixa Biosciences, Inc. develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company is also developing immuno-therapy drugs against cancer.